MALVERN, PA — TELA Bio, Inc. (Nasdaq: TELA), a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, announced that the company plans to participate in two upcoming investor conferences.
TELA Bio’s management will be participating in the Jefferies Virtual London Healthcare Conference on Tuesday, November 17, 2020, at 10:15 AM EST. Interested parties may access a live audio webcast of the presentation by visiting the “Investors” section of the company’s website at ir.telabio.com.
TELA Bio’s management is also scheduled to present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum on Thursday, November 19, 2020, at 10:30 AM EST. Interested parties can access the live and archived webcast at ir.telabio.com.
Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.